Fritextsökning
Innehållstyper
-
Trio goes in for high tech medicines
The Swedish drug discovery company Beactica announces fragment-based drug discovery research collaboration with GE Healthcare and the University of Uppsala.
-
Mingling do's and don'ts
Linkedin, Facebook, MSN and Gmail are all perfect tools for the urban businessman or woman to keep track of and stay up-to-date with contacts. "But in the end, ...
-
Diamyd förlikar i licenstvist
Ger University of Florida en del av ersättningen de fick från affären med Ortho-McNeil-Janssen.
-
Dry blood DNA storage on a matrix
Qiagen recently presented a method of dry blood sample storage as an alternative to storage in freezers.
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Think outside the... brain
Riitta Hari from the Brain Research Unit at the Helsinki University of Technology has recently stated that the mind is more than just the brain.
-
Biotech goes white and bright
White biotech could become Denmark's next blossoming business area.
-
Satsar på tidig forskning
Tillsammans med tre universitet skapar Astrazeneca, GSK och Johnson and Johnson en fond för utveckling av prekliniska projekt.
-
New tools to fight bacteria
Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Säkerhetsbrister på barnsjukhus
Knäckte lösenorden till skyddade dokument från prövningar
-
Grape extract kills cancer cells
Grapes contain potentially beneficial chemicals that can destroy cancer cells, a new research proves.
-
535 miljoner till regenerativ medicin
Knut och Alice Wallenbergs Stiftelse finansierar ett nytt forskningscentrum i Lund.
-
Första Crispr-bolaget till börsen
Editas Medicine blir det första bolaget på börsen med fokus på det omtalade genmodifieringsverktyget Crispr/Cas9.
-
Sprint får ny vetenskaplig rådgivare
Cancerforskaren Ravi Amaravadi från USA ska hjälpa bolaget till klinisk fas.
-
Infidelity produces faster sperms
Until now, it has been difficult to prove that fast-swimming sperms have an advantage when it comes to fertilizing an egg.
-
Nytt namn i Symphogens ledning
Adriann Sax har utsetts till affärschef på det danska företaget.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Få överraskningar i rapporten
Pledpharmas kvartalsrapport bjöd inte på några stora nyheter men planerna på diskussioner med FDA och potentiella samarbetspartners ligger fast.
-
Swedish cancer therapy granted
Pledpharma, Linköping University and Ryhov County Hospital receive a research grant from the Research Council FORSS to conduct clinical studies in cancer patients.
-
Smarta män tar sin medicin
Generell kognitiv förmåga har visat sig spela roll för hur väl män tar sin ordinerade medicin efter en hjärtinfarkt. Det visar en ny studie från Umeå och Uppsala universitet.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.